Aducanumab: What about the Patient?

Ann Neurol. 2021 Sep;90(3):334-335. doi: 10.1002/ana.26181. Epub 2021 Aug 7.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Alzheimer Disease / drug therapy*
  • Alzheimer Disease / psychology*
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Clinical Decision-Making / methods*
  • Drug Approval / methods
  • Humans

Substances

  • Antibodies, Monoclonal, Humanized
  • aducanumab